ALK c.1282+20255G>T

Variant ID: 2-29586343-C-A

NM_004304.4(ALK):c.1282+20255G>T

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma.

Cancers
Cabibbo, Giuseppe G; Celsa, Ciro C; Enea, Marco M; Battaglia, Salvatore S; Rizzo, Giacomo Emanuele Maria GEM; Busacca, Anita A; Matranga, Domenica D; Attanasio, Massimo M; Reig, Maria M; Craxì, Antonio A; Cammà, Calogero C
Publication Date: 2020-12-30

Variant appearance in text: rs13010090
PubMed Link: 33396833
Variant Present in the following documents:
  • Main text
  • cancers-13-00090.pdf
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs13010090
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page